Synapse - Genitourinary Oncology Service

Results (5687)

Testosterone Recovery and Associated Impact on PatientReported Health -Related Quality of Life (HRQoL) after Treatment with 6 Months of GnRH Agonist with or without Abiraterone Acetate plus Prednisone (AAP) and Apalutamide (Apa) in the FORMULA-509 Trial

Meeting Abstract

Moningi, S.; Nguyen, P. L.; Rathkopf, D.; Zurita-Saavedra, A.; Spratt, D. E.; Dess, R. T.; Liauw, S.; Szmulewitz, R.; Einstein, D. J.; Bubley, G.; more...
International Journal of Radiation Oncology, Biology, Physics (2024)

Fulltext@MSK | Save

Stereotactic radiosurgery and whole brain radiotherapy for germ cell tumor brain metastases: Practice patterns and outcomes

Meeting Abstract

Gui, C.; Funt, S.; Boe, L. A.; Yu, Y.; Zinovoy, M.; Chen, L.; Yamada, Y.; Pike, L. R. G.; Feldman, D.; Imber, B. S.
International Journal of Radiation Oncology, Biology, Physics (2024)

Fulltext@MSK | Save

UPLIFT (ENGOT-ov67/GOG-3048): Results from the phase II trial of upifitamab rilsodotin, a NaPi2b-directed dolaflexin antibody-drug conjugate, in platinum-resistant ovarian cancer

Meeting Abstract

Richardson, D.; Iyer, G.; Schmid, A.; Palma, N.; Navarro, W.; Ahnert, J. R.
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Tumour dosimetry across 6 cycles of [(177)Lu]LuPSMA-617 in patients with metastatic castrationresistant prostate cancer: Results from the VISION substudy

Meeting Abstract

Herrmann, K.; Krause, B.; Chi, K.; Sartor, O.; Fizazi, K.; Morris, M. J.; De Bono, J.; Tagawa, S.; Kurth, J.; Eiber, M.; more...
European Journal of Nuclear Medicine and Molecular Imaging (2024)

Fulltext@MSK | Save

NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors (trial in progress)

Meeting Abstract

Baldini, C.; Patnaik, A.; Lakhani, N.; Call, J.; Galsky, M.; Garmezy, B.; Wei, A.; Carter, L.; Powles, T.; Siefker-Radtke, A.; more...
European Journal of Cancer (2024)

Fulltext@MSK | Save

Targeted CRISPR-Knockout (KO) screening to identify FOXF1 regulators and therapeutic strategies in gastrointestinal stromal tumor (GIST)

Meeting Abstract

Tomas, F.; Cho, W. H.; Li, D.; Callychurn, V. R.; Wang, N.; Yu, C.; Chi, P.
European Journal of Cancer (2024)

Fulltext@MSK | Save

Preliminary safety and anti-tumor activity of TYRA-300, a highly selective FGFR3 inhibitor, in participants with advanced solid tumors with activating FGFR3 mutations/fusions (SURF301)

Meeting Abstract

Tran, B.; Boni, A.; Hansen, A.; Boni, V.; Mantia, C.; Yu, E.; Weickhardt, A.; Robert, M.; Gupta, S.; Necchi, A.; more...
European Journal of Cancer (2024)

Fulltext@MSK | Save

TYRA-300, an oral, FGFR3-selective inhibitor: Preliminary pharmacokinetic and pharmacodynamic analysis from SURF301, the multicenter open-label phase 1/2 study of TYRA-300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 alterations

Meeting Abstract

Loriot, Y.; Zhang, A.; Hansen, A.; Mantia, C.; Boni, V.; Weickhardt, A.; Yu, E. Y.; Robert, M.; Iyer, G.; Murtha, A.; more...
European Journal of Cancer (2024)

Fulltext@MSK | Save

A Multicenter, open-label phase 1/2 study of TYRA 300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 gene alterations (SURF301)

Meeting Abstract

Zhang, A.; Boni, V.; Hanson, A.; Mantia, C.; Weickhardt, A.; Yu, E.; Gupta, S.; Robert, M.; Iyer, G.; Millward, M.; more...
European Journal of Cancer (2024)

Fulltext@MSK | Save

Trends in enforcement of National Comprehensive Cancer Network financial conflict of interest policy

Journal Article

Saririan, N.; Bhamidipati, D.; Dey, P.; Persaud, S.; Chakraborty, N.; Tabatabai, S.; Gallagher, G.; Trivedi, N. U.; Mitchell, A. P.
JNCI Cancer Spectrum (2024)

Fulltext@MSK | Save